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1. INTRQDUCTiON 
In non-muscle cells, actin participates in motile pro- 
cesses. Furthermore, the cytoskeletal actin plays a key 
role in the cellular architecture. The functions of actin 
depend on the reversible polymerization of monomeric 
G-actin forming filamentous F-actin. The dynamic pro- 
cess of polymerization and depolymerization is ap- 
parently tiontrolled by a number of actin-binding pro- 
teins [1,2]. On the other hand, the ratio of monomeric 
to polymeric actin might influence the actin synthesis 
[3]. Using toxins like CIostridium botulinurn C2 toxin 
and phalloidin which specifically shift the cellular G- 
/F-actin state to the monomeric and to the polymeric 
form, respectively, we studied the influence of the 
relative G- and F-actin levels on the synthesis of actin in 
cultured hepatocytes. C2 toxin specifically ADP- 
ribosylates non-muscle G-actin in vitro and in intact 
cells [4,5]. ADP-ribosylated G-actin acts like a capping 
protein at the fast growing end of F-actin which inhibits 
further polymerization [6]. Since depolymerization, on 
the other hand, is not affected, C2 toxin increases the 
pool of monomeric G-actin in intact cells [7]. In con- 
trast, binding of the mycotoxin phalloidin to F-actin 
dramatically reduces actin depolymerization resulting 
in a decreased pool of G-actin [8]. Studies with 
phalloidin are hampered by the fact that the mycotoxin 
is not able to enter most cells. Therefore, in the present 
study rat hepatocytes in primary cultures were used, 
which selectively take up phalloidin [9]. 
The present investigation demonstrates that the level 
of actin mRNA and the synthesis of actin are under 
autoregulatory control by the G-/F-actin ratio in rat 
hepatocytes imilar to the autoregulation of tubulin 
synthesis by tubulin monomers [lo- 141. 
2. MATERIALS AND METHODS 
2. I. Cell culwes, protein distribution and gel electrophoresis 
Hepatocytes isolated from Wistar rats were cultured as described 
previously [15]. Ail experiments were performed with hepatocytes 
maintained in primary culture for 24-48 h. The cells were treated up 
to 20 h without or with C2 toxin (1 &ml) or with phalloidin 
(I-2.5 @g/ml), respectively. Thereafter, [‘4C]leucine (6.5 Ci/mol) 
was added for further 4 h. For separation of cytoskeletal and 
cytosolic proteins, the cellq were lysed by addition of buffer contain- 
ing Triton X-100 (2% v/v) as described [16]. The insoluble 
cytoskeletal proteins including F-actin were separated from soluble 
proteins including G-actin by centrifugation for 10 min at 10000 x g, 
The supernatant proteins were concentrated by precipitation with 
methanol and chloroform. The pellets of cytoskeletal proteins and of 
cytosolic proteins were dissolved in SDS sample buffer [17] and sub- 
jected to SDS-polyacrylamide gel electrophoresis (PAGE) [ 171. Gels 
were stained with Coomassie blue, dried and subjected to 
autoradiography up to 14 days at -7O’C (Fig. IA). Ths quantitation 
of stained gels and of autoradiographs was performed by den- 
sitometry. In addition, the 43 kDa protein band was excised for deter- 
mination of the radioactivity in a liquid scintillation counter. 
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Moreover the celluiar concentration of G-actin was measured by 
determinaticn of the bciective inhibition of DNase I by monomeric ac- 
tin 1181 using a modified lysis buffer 1191, 
The degradation of total cellular actin was determined in a pulse- 
chaseexperitncnt: after 12 h of incubation in the presence of 0.45 mM 
[‘*C]leucine (0.9 Ci/mol) the medium 199 was removed and the cell 
monolayers were washed 3 times with medium containing 2.5 mM 
unlabelled leucine. The decrease of radioactivity in the 43 kDa pro- 
tein of cell lysates was monitored up to 48 h in the presence of 
medium 199 containing 2.5 mM leucine. 
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ADP-ribosylation of actin by CIosrridium borulinum C2 toxin resulted in a depolymerization of filamentous F-a&n and an increase of monomeric 
G-actin in cultured hepatocytes. Simultaneously the de nova synthesis of actin was largely reduced, while the synthesis of albumin and of other 
proteins was not significantly impaired. The specific decrease of actin mRNA to 30% of the control indicates a down-regulation of actin synthesis 
at a pretranslational level. On the other hand, treatment with the mycotoxin phalloidin resulted in an increase of F-actin and a decrease of mono- 
meric G-actin. Under this condition the de novo synthesis of actin was specifically enhanced and the level of actin mRNA was increased to 600% 
of the control. The data suggest an autorcgulatory control of the actin synthesis. 
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2.2. Identvication of actin 
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of the cytosolic G-actin pool (Fig. IA). As determined 
by inhibition of DNase I activity [lg], the cellular con- 
centrations of monomeric G actin per mg cytosolic pro- 
tein were 10.3 /Ig in untreated hepatocytss, 19.3 pg 
after 14 h of treatment with C2 toxin and 0.7 bg after 
14 h of treatment with phalloidin. 
In order to study the de novo synthesis of actin, in- 
corporation of [‘%]leucine into newly synthesized 
cellular proteins was measured. The incorporation of 
[14C]leucine into the 43 kDa protein was clearly altered 
by treatment with C2 toxin and with phalloidin, respec- 
tively, while the labelling of the total precipitable pro- 
tein (not shown) and of other single proteins was essen- 
tially unchanged. The incorporation of [‘4C]leucine in- 
to the 43 kDa protein was largely enhanced after 
phalloidin treatment with predominance of the label in 
the Triton-insoluble cytoskeletal fraction as compared 
to the control (Fig. IA, right side). On the other hand, 
the incorporation was drastically reduced after C2 toxin 
treatment in the cytosolic as well as in the cytoskeletal 
fractions of hepatocytes. The intracellular degradation 
of actin was slightly modulated by C2 toxin and by 
phalloidin. In the absence of toxins, 24% of the 43 kDa 
protein was lost within 24 h; the degradation was in- 
creased to 34% in the presence of C2 toxin while it was 
decreased to 17% in the presence of phalloidin. Due to 
the long half-life of actin, these alterations may con- 
tribute only slightly to the observed changes of cellular 
actin observed in the presence of C2 toxin or phalloidin. 
In order to identify the 43 kDa protein as actin, 
lysates of [‘4C]leucine labelled cells were applied onto 
DNase I columns, which specifically bind G-actin and 
ADP-ribosylated G-actin [6,20]. Actin eluted from the 
DNase I affinity columns by formamide was identified 
as 43 kDa protein on SDS-PAGE (Fig. 1B). As shown 
by autoradiography of the gel, incorporation of 
[14C]leucine into actin was largely reduced after C2 
toxin treatment indicating an inhibition of actin syn- 
thesis. Furthermore, radioactively labelled actin of con- 
trol and toxin-treated cells was identified by im- 
munoblotting using a monoclonal anti-actin antibody 
(Fig. 1C). Again, the autoradiography of the labelled 
proteins indicates that the actin synthesis was decreased 
after C2 toxin treatment while it was increased after 
treatment with phalloidin. 
Cultured hepatocytes were treated with or without botulinum C2 
toxin for 24 h. Thereafter, [‘“C]leucine (0.5 Ci/mol) was added for 
6 h. The cells were lysed in the presence of F-actin depolymerizing 
buffer as described [20]. After homogenizing and centrifugation for 
I h at 100000 x g, the supernatants were applied to columns of DNase 
l-coupled Sepharose 413 which specifically bind G-actin [20,21]. The 
columns were washed and actin was eluted with formamide as describ- 
ed [20]. The eluates were collected and precipitated by trichloroacetic 
acid for separation on SDS-PAGE as described above. The gel was 
stained with Coomassie blue and subjected to autoradiography for 
about 6 weeks at -70°C (Fig. IB). For immunoblot analysis the 
radio-labelled cytosolic proteins were subjected to SDS-PAGE. 
Thereafter, immunoblotting was performed according to Towbin et 
al. [22] using monoclonal mouse anti-actin antibodies (ICN), 
peroxidase-coupled rabbit anti-mouse IgG antibodies (Sigma) and 
4-chloro-I-naphthol as peroxidase substrate. The immunoblot was 
subjected to autoradiography for 20 days at -70°C (Fig. IC). 
2.3. Delection and quantitation of actin and albumin m&VA 
RNA of cultured hepatocytes was isolated according to Chomczyn- 
ski and Sacchi [23]. For Northern blot analysis total RNA (IO ,~g per 
lane) was subjected to electrophoresis on agarose gel (1% w/v), con- 
taining 2.2 M formaldehyde [24]. RNA was transferred to a 
nitrocellulose filter (Hybond-C extra, Amersham); hybridization was 
performed at 42°C in a mix containing formamide (50% V/V) 1241 us- 
ing 32P-labelled random primed cDNA [25]. As probes, a 1.3 kb Psrl 
fragment of mouse&actin cDNA [26] cloned into standard bluescript 
vector (Stratagene, La Jolla, CA) and a 0.8 kb fstl fragment of rat 
albumin cDNA [27] cloned into pBR322 were used. The filters were 
washed once in I x SSPE-buffer (I50 mM NaCI, I mM EDTA and 
IO mM sodium phosphate, pH 7.4) containing SDS (0.1% w/v) at 
room temperature followed by washing three times in 0.1 x SSPE 
containing SDS (0.1%) each for 20 min at 60°C. The filters were sub- 
jected to autoradiography for 12-24 h and the hybridization signals 
were quantified by scanning densitometry. 
In order to test a transcriptional regulation, cultured hepatocytcs 
were incubated for up to 24 h in the presence of phalloidin 
(2.5 fig/ml) with or without actinomycin D (6 ,uM), which prevented 
the transcription by more than 95% without significant alterations in 
cell morphology. The quantitation of actin mRNA was performed by 
dot blot analysis; the dots were localized by autoradiography and ex- 
cised for determination of the radioactivity in a liquid scintillation 
counter. All experiments were performed with triplicates; mean 
values are given. Statistical analysis was performed using Student’s I- 
test. 
3. RESULTS 
3.1. Influence of C2 toxin and of phalloidin on the 
cellular concentration and synthesis of actin 
The cellular concentrations of monomeric G-actin 
and of polymeric F-actin were studied after separation 
of the two forms of actin using Triton X-100 [16]. 
Treatment with C2 toxin increased the cellular concen- 
tration of a 43 kDa protein soluble in Triton X-100 con- 
taining buffer, which was identified later on to be 
monomeric actin; it decreased the amount of a Triton 
X-lOO-insoluble 43 kDa protein, which represented 
filamentous actin (Fig. IA, left side). A similar shift to 
G-actin was described previously in cultures of chicken 
fibroblasts after treatment with C2 toxin [5,7]. An in- 
verse distribution of actin was observed after phalloidin 
treatment, which resulted in an increase of 
cytoskeleton-associated F-actin and a relative decrease 
Enhancement of G-actin in the cytosolic pool and in- 
hibition of actin synthesis by botulinum C2 toxin was 
accompanied by a dose-dependent ADP-ribosylation of 
intracellular actin. Neither C2 toxin nor phalloidin 
treatment of hepatocytes resulted in a significant in- 
crease of the release of typical hepatocellular enzymes 
indicating the cellular integrity (not shown), 
3.2. Molecular mechanism of the toxin-dependent 
modulation of actin synthesis 
The molecular mechanism of the described toxin- 
dependent modulation of actin synthesis was studied by 
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Fig. I. Influence of botulinum C2 toxin (C2T; 1 &ml) and of phalloidin (PHAL; 1 pg/ml) on the amount of cytosolic and cytoskeletal proteins 
and on protein synthesis in cultured rat hepatocytes (4 = control). (A) Distribution of cytosolic and cytoskeletal proteins in Triton X-100 soluble 
(A) and insoluble (8) fractions. Left side: SDS.PAGE, Right side: autoradiography after labelling with [‘“Cjleucine. The position of actin on the 
SDS-PAGE is indicated by its molecular mass of 43 kDa. (B) Isolation of cellular actin by affinity chromatography on DNasc I. (C) Identification 
of cellular actin by immunoblotting. 
determination of the actin mRNA levels. Northern blot 
analysis using [32P]cDNA shows that treatment of 
hepatocytes with C2 toxin decreased the actin mRNA 
level to about 30% whereas phalloidin largely increased 
the amount of actin mRNA to about 600% of the con- 
trol (Fig, 2). In order to distinguish whether the in- 
crease of specific mRNA was due to an enhanced 
transcription or to a decreased egradation of mRNA, 
the effect of phalloidin was studied in the presence of 
actinomycin D. As demonstrated by dot blot analysis, 
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Fig. 2. Northern blot analysis of actin mRNA and albumin mRNA 
from cultured rat hepatocytes. (A) After 9 h incubation and (B) after 
17 h incubation. The cells were treated without (q5) or with C2 toxin 
(CtT; I ,ug/ml) or with phalloidin (PHAL; 2.5 &ml), respectively. 
the phalloidin-dependent increase of actin mRNA was 
completely prevented in the presence of actinomycin D 
indicating a transcriptional regulation (not shown). In 
contrast, treatment of hepatocytes with either toxin did 
not significantly affect the albumin mRNA, a finding 
which is in agreement with the selectivity of the toxin’s 
effects on actin synthesis. 
4. DISCUSSION 
The present study demonstrates that botulinum C2 
toxin and phalloidin exhibit antagonistic effects on the 
G-/F-actin equilibrium and on actin synthesis in intact 
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cultured hepatocytes. C2 toxin increased the cytosolic 
monomeric G-actin pool; it decreased actin synthesis 
and the amount of actin mRNA specifically. On the 
other hand, phalloidin shifted the CL/I?-actin ratio to 
the cytoskeletal F-actin; actin synthesis and the amount 
of actin mRNA were specifically enhanced at the 
transcriptional level. 
Quite recently, it has been reported that in 
phalloidin-treated fibroblasts G-actin was decreased 
whereas actin synthesis was increased; an 
autoregulatory control of actin synthesis by G-actin was 
proposed 131. However, the influence of enhanced 
cellular concentrations of G-actin on actin synthesis 
was not tested, a direct modulation of actin synthesis by 
phalloidin was not excluded and the specificity of the 
observed increase of actin mRNA was not documented. 
Since in the present study C2 toxin and phalloidin ex- 
hibited specific reciprocal effects on the intracellular 
level of G-actin and on actin synthesis, it is most likely 
that actin synthesis was modulated by the cellular con- 
centrations of G-actin rather than by direct effects of 
the two structurally different toxins. Thus, an 
autoregulatory control of actin synthesis by the G-/F- 
actin ratio can be assumed. 
A similar regulation was previously described for the 
synthesis of tubulin. Agents like colchicine, nocodazole 
or colcemid which cause microtubule depolymerization 
and an increase in unpolymerized tubulin subunits, 
decrease tubulin synthesis [10,13]. Furthermore, 
microinjection of purified tubulin selectively inhibits 
tubulin production [ 123. These effects are accompanied 
by a decrease in the tubulin mRNA [l I]. 
Interactions between protein synthesis and the 
cytoskeleton apparently exist. Pt has been reported that 
mRNA coding for proteins of the cytoskeleton is 
associated with cytoskeletal structures [28,29]. The 
release of mRNA from the cytoskeleton reduced the 
total protein synthesis by a decrease in the translation of 
the mRNA [30]. In this study high concentrations of 
cytochalasin D were used, which effected rear- 
rangements of the cytoplasmic architecture without 
diminishing or disaggregating the cytoskeletal network 
or changing the G-/F-actin ratio [30]. The effects of C2 
toxin and phalloidin observed in the present study are 
apparently not mediated by this mechanism, since 
overall protein synthesis was not significantly impaired, 
the level of actin mRNA was specifically modulated and 
inhibition of the transcription prevented the phalloidin 
dependent enhancement of actin mRNA. Thus, the 
data suggest that the actin synthesis in intact 
hepatocytcs is under autoregulatory control of the G- 
/F-actin ratio similar to the autoregulation of tubulin 
synthesis by a shift of polymerized to unpolymerized 
tubulin. 
In vitro studies recently demonstrated that not only 
F-actin but also G-actin bind to isolated hepatocellular 
membranes with similar affinities [31]. Although the 
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physiological significance of the G-actin binding is not I121 Cleveland, D.W., Pittenger, M.F. and Feramisco, J.R. (1983) 
clear, it cannot be excluded that the equiiibriim be- 
tween unbound and membrane-bound G-actin is in- 
volved in the observed autoregulation of actin syn- 
thesis. Further studies will be necessary to answer this 
question. 
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